MTOR and gastric cancer: Knockdown of KRT17 using targeting siRNA has been shown to significantly suppress gastric cancer cell proliferation (42.36 ± 3.2%) and migration (37.2 ± 6.2%) through the AKT/mTOR pathway [34].